nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—urine—bipolar disorder	0.0244	0.131	CbGeAlD
Tolterodine—CYP2C9—urine—bipolar disorder	0.0189	0.102	CbGeAlD
Tolterodine—CYP3A4—urine—bipolar disorder	0.0144	0.0777	CbGeAlD
Tolterodine—CYP2D6—urine—bipolar disorder	0.0142	0.0765	CbGeAlD
Tolterodine—CYP2C19—blood plasma—bipolar disorder	0.0128	0.0686	CbGeAlD
Tolterodine—CYP2C9—blood plasma—bipolar disorder	0.00989	0.0532	CbGeAlD
Tolterodine—Orphenadrine—GRIN1—bipolar disorder	0.00935	0.331	CrCbGaD
Tolterodine—CHRM4—nervous system—bipolar disorder	0.00933	0.0502	CbGeAlD
Tolterodine—CYP3A4—blood plasma—bipolar disorder	0.00754	0.0406	CbGeAlD
Tolterodine—CYP2D6—blood plasma—bipolar disorder	0.00742	0.0399	CbGeAlD
Tolterodine—CHRM5—nervous system—bipolar disorder	0.0073	0.0393	CbGeAlD
Tolterodine—CHRM4—brain—bipolar disorder	0.00713	0.0384	CbGeAlD
Tolterodine—CHRM5—brain—bipolar disorder	0.00558	0.03	CbGeAlD
Tolterodine—CHRM2—nervous system—bipolar disorder	0.00501	0.0269	CbGeAlD
Tolterodine—CHRM3—thyroid gland—bipolar disorder	0.00485	0.0261	CbGeAlD
Tolterodine—CHRM1—nervous system—bipolar disorder	0.00456	0.0245	CbGeAlD
Tolterodine—Chlorphenamine—SLC6A3—bipolar disorder	0.00423	0.15	CrCbGaD
Tolterodine—CHRM3—nervous system—bipolar disorder	0.00408	0.0219	CbGeAlD
Tolterodine—CHRM2—brain—bipolar disorder	0.00383	0.0206	CbGeAlD
Tolterodine—KCNH2—nervous system—bipolar disorder	0.00362	0.0195	CbGeAlD
Tolterodine—Atomoxetine—SLC6A3—bipolar disorder	0.00355	0.126	CrCbGaD
Tolterodine—CHRM1—brain—bipolar disorder	0.00348	0.0187	CbGeAlD
Tolterodine—KCNH2—cerebellum—bipolar disorder	0.0034	0.0183	CbGeAlD
Tolterodine—Atomoxetine—HTR2C—bipolar disorder	0.00321	0.114	CrCbGaD
Tolterodine—Chlorphenamine—SLC6A4—bipolar disorder	0.00316	0.112	CrCbGaD
Tolterodine—CHRM3—brain—bipolar disorder	0.00312	0.0168	CbGeAlD
Tolterodine—KCNH2—brain—bipolar disorder	0.00276	0.0149	CbGeAlD
Tolterodine—Atomoxetine—SLC6A4—bipolar disorder	0.00266	0.0942	CrCbGaD
Tolterodine—CYP3A4—nervous system—bipolar disorder	0.00224	0.0121	CbGeAlD
Tolterodine—CYP2D6—nervous system—bipolar disorder	0.00221	0.0119	CbGeAlD
Tolterodine—CYP2D6—cerebellum—bipolar disorder	0.00208	0.0112	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—bipolar disorder	0.00204	0.0724	CrCbGaD
Tolterodine—CYP2D6—brain—bipolar disorder	0.00169	0.00907	CbGeAlD
Tolterodine—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	0.00024	0.000306	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TAC1—bipolar disorder	0.00024	0.000305	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RGS4—bipolar disorder	0.000239	0.000305	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TAC1—bipolar disorder	0.000237	0.000302	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HTR2A—bipolar disorder	0.000236	0.0003	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	0.000236	0.0003	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.000236	0.0003	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NDUFV2—bipolar disorder	0.000235	0.000299	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD1—bipolar disorder	0.000235	0.000299	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2C—bipolar disorder	0.000235	0.000299	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2C—bipolar disorder	0.000233	0.000296	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD1—bipolar disorder	0.000233	0.000296	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.00023	0.000292	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADCY2—bipolar disorder	0.000229	0.000291	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	0.000228	0.00029	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKR1C4—bipolar disorder	0.000228	0.00029	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD3—bipolar disorder	0.000228	0.00029	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000227	0.000289	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000227	0.000289	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD2—bipolar disorder	0.000227	0.000288	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HTR2A—bipolar disorder	0.000226	0.000288	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD3—bipolar disorder	0.000225	0.000287	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—POMC—bipolar disorder	0.000225	0.000286	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD2—bipolar disorder	0.000224	0.000286	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—POMC—bipolar disorder	0.000224	0.000285	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—POMC—bipolar disorder	0.000222	0.000283	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000222	0.000282	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD4—bipolar disorder	0.000221	0.000281	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD4—bipolar disorder	0.000219	0.000278	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000216	0.000275	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR2A—bipolar disorder	0.000214	0.000273	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000214	0.000273	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR1A—bipolar disorder	0.000214	0.000272	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CLOCK—bipolar disorder	0.000213	0.000271	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TAC1—bipolar disorder	0.000211	0.000268	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.000209	0.000266	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.000209	0.000265	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADCY2—bipolar disorder	0.000208	0.000265	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TSHB—bipolar disorder	0.000208	0.000264	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TPH2—bipolar disorder	0.000208	0.000264	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CACNB2—bipolar disorder	0.000208	0.000264	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000208	0.000264	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2C—bipolar disorder	0.000207	0.000263	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD1—bipolar disorder	0.000207	0.000263	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	0.000206	0.000263	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADCY2—bipolar disorder	0.000206	0.000262	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD2—bipolar disorder	0.000206	0.000262	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR2A—bipolar disorder	0.000205	0.000261	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR1A—bipolar disorder	0.000205	0.000261	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NR1D1—bipolar disorder	0.000204	0.00026	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—DPYD—bipolar disorder	0.000204	0.00026	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD2—bipolar disorder	0.000204	0.000259	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TAC1—bipolar disorder	0.000202	0.000257	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NTRK2—bipolar disorder	0.000201	0.000256	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD3—bipolar disorder	0.0002	0.000254	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GSK3A—bipolar disorder	0.000199	0.000253	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2C—bipolar disorder	0.000198	0.000252	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD1—bipolar disorder	0.000198	0.000252	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NCAN—bipolar disorder	0.000196	0.000249	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD4—bipolar disorder	0.000194	0.000247	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NTRK2—bipolar disorder	0.000192	0.000245	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SLC5A3—bipolar disorder	0.000192	0.000244	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD3—bipolar disorder	0.000192	0.000244	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GSK3A—bipolar disorder	0.000191	0.000243	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CACNA1C—bipolar disorder	0.00019	0.000242	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—POMC—bipolar disorder	0.000189	0.00024	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000188	0.000239	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	0.000187	0.000238	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TRPC3—bipolar disorder	0.000187	0.000238	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000186	0.000237	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD4—bipolar disorder	0.000186	0.000237	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000186	0.000237	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3C2A—bipolar disorder	0.000185	0.000235	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	0.000185	0.000235	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADCY2—bipolar disorder	0.000183	0.000233	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TCF7L2—bipolar disorder	0.000182	0.000232	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD2—bipolar disorder	0.000181	0.00023	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—POMC—bipolar disorder	0.000181	0.00023	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NCAN—bipolar disorder	0.00018	0.000229	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000179	0.000227	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000178	0.000227	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADM—bipolar disorder	0.000178	0.000227	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADM—bipolar disorder	0.000176	0.000225	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000176	0.000224	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADCY2—bipolar disorder	0.000175	0.000223	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000175	0.000222	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TCF7L2—bipolar disorder	0.000174	0.000222	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000174	0.000222	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000174	0.000222	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000174	0.000222	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	0.000174	0.000221	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TACR1—bipolar disorder	0.000174	0.000221	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TSHB—bipolar disorder	0.000174	0.000221	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD2—bipolar disorder	0.000173	0.00022	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	0.000172	0.000219	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TSHB—bipolar disorder	0.000172	0.000219	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TACR1—bipolar disorder	0.000172	0.000219	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—POMC—bipolar disorder	0.000171	0.000218	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000166	0.000212	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SNAP25—bipolar disorder	0.000166	0.000211	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—POMC—bipolar disorder	0.000164	0.000209	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NTRK1—bipolar disorder	0.000164	0.000208	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000159	0.000203	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—S100B—bipolar disorder	0.000159	0.000203	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	0.000159	0.000202	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000157	0.0002	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NTRK1—bipolar disorder	0.000157	0.0002	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—S100B—bipolar disorder	0.000152	0.000194	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ADCY2—bipolar disorder	0.000147	0.000187	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000145	0.000184	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000144	0.000183	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	0.000144	0.000183	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	0.000144	0.000183	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	0.000143	0.000182	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	0.000142	0.000181	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.000142	0.000181	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TAC1—bipolar disorder	0.000142	0.00018	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000141	0.00018	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NRG1—bipolar disorder	0.000141	0.000179	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TAC1—bipolar disorder	0.00014	0.000178	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000139	0.000177	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000139	0.000177	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD1—bipolar disorder	0.000139	0.000177	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	0.000139	0.000177	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CLOCK—bipolar disorder	0.000139	0.000176	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD1—bipolar disorder	0.000137	0.000175	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	0.000137	0.000175	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000137	0.000174	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CACNB2—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TPH2—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TSHB—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.000135	0.000172	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NRG1—bipolar disorder	0.000135	0.000171	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD3—bipolar disorder	0.000134	0.000171	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000134	0.000171	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	0.000134	0.00017	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	0.000134	0.00017	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD3—bipolar disorder	0.000133	0.000169	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—DPYD—bipolar disorder	0.000133	0.000169	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	0.000133	0.000169	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000131	0.000167	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD4—bipolar disorder	0.000131	0.000166	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD4—bipolar disorder	0.000129	0.000164	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.000127	0.000162	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	0.000127	0.000162	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	0.000127	0.000161	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	0.000127	0.000161	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000126	0.000161	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—COMT—bipolar disorder	0.000126	0.00016	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	0.000126	0.00016	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MAOA—bipolar disorder	0.000125	0.000159	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000124	0.000158	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000124	0.000158	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000124	0.000158	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	0.000123	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000123	0.000157	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TSHB—bipolar disorder	0.000123	0.000157	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.000123	0.000157	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TPH2—bipolar disorder	0.000123	0.000157	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NR1D1—bipolar disorder	0.000123	0.000156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	0.000123	0.000156	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.000123	0.000156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	0.000122	0.000156	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000122	0.000155	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	0.000122	0.000155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	0.000122	0.000155	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD2—bipolar disorder	0.000122	0.000155	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	0.000121	0.000154	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	0.000121	0.000154	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DPYD—bipolar disorder	0.000121	0.000154	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD2—bipolar disorder	0.00012	0.000153	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	0.00012	0.000153	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000119	0.000151	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NCAN—bipolar disorder	0.000118	0.00015	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	0.000115	0.000147	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	0.000115	0.000147	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—bipolar disorder	0.000115	0.000146	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—bipolar disorder	0.000114	0.000145	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	0.000114	0.000144	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.000113	0.000143	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	0.000111	0.000141	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	0.00011	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	0.00011	0.00014	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.00011	0.00014	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	0.000109	0.000139	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000108	0.000138	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SNAP25—bipolar disorder	0.000108	0.000137	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—S100B—bipolar disorder	0.000107	0.000137	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—S100B—bipolar disorder	0.000107	0.000136	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—S100B—bipolar disorder	0.000106	0.000135	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	0.000102	0.00013	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—bipolar disorder	0.000102	0.000129	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—bipolar disorder	0.000101	0.000129	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—INS—bipolar disorder	0.000101	0.000128	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SNAP25—bipolar disorder	9.93e-05	0.000126	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SNAP25—bipolar disorder	9.84e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	9.77e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—bipolar disorder	9.69e-05	0.000123	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—INS—bipolar disorder	9.64e-05	0.000123	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADCY2—bipolar disorder	9.55e-05	0.000122	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	9.47e-05	0.000121	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NRG1—bipolar disorder	9.44e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NRG1—bipolar disorder	9.35e-05	0.000119	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADCY2—bipolar disorder	8.78e-05	0.000112	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADCY2—bipolar disorder	8.71e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	8.54e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	8.52e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	8.43e-05	0.000107	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CLOCK—bipolar disorder	8.33e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—COMT—bipolar disorder	8.18e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—bipolar disorder	8.13e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MAOA—bipolar disorder	8.12e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TSHB—bipolar disorder	8.12e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TPH2—bipolar disorder	8.12e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNB2—bipolar disorder	8.12e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—INS—bipolar disorder	8.09e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DPYD—bipolar disorder	7.99e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—COMT—bipolar disorder	7.52e-05	9.57e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MAOA—bipolar disorder	7.47e-05	9.5e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—COMT—bipolar disorder	7.46e-05	9.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	7.42e-05	9.45e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOA—bipolar disorder	7.4e-05	9.42e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	7.24e-05	9.21e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	6.88e-05	8.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	6.86e-05	8.72e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—bipolar disorder	6.82e-05	8.68e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—bipolar disorder	6.8e-05	8.65e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	6.79e-05	8.64e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—bipolar disorder	6.78e-05	8.63e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—bipolar disorder	6.76e-05	8.6e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—bipolar disorder	6.73e-05	8.57e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—bipolar disorder	6.7e-05	8.52e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—bipolar disorder	6.61e-05	8.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SNAP25—bipolar disorder	6.49e-05	8.26e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—bipolar disorder	6.08e-05	7.74e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—bipolar disorder	6.03e-05	7.67e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADCY2—bipolar disorder	5.74e-05	7.31e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—bipolar disorder	5.29e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—bipolar disorder	5.26e-05	6.69e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—COMT—bipolar disorder	4.92e-05	6.26e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOA—bipolar disorder	4.88e-05	6.21e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—bipolar disorder	4.86e-05	6.19e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—bipolar disorder	4.84e-05	6.15e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—bipolar disorder	4.82e-05	6.13e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—bipolar disorder	4.79e-05	6.1e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—bipolar disorder	3.98e-05	5.06e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—bipolar disorder	3.18e-05	4.05e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—bipolar disorder	3.16e-05	4.02e-05	CbGpPWpGaD
